Novartis Bioventures Ltd insider trades: Akouos (AKUS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Novartis Bioventures Ltd reports to the SEC
and 8 more companies
Open-market buys and sales
62 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 30, 2020 | AKUS | ↑ Buy | 125,000 | $17.00 | $2.1M | Indirect | Jul 2, 2020 (2d) |
| Jun 19, 2020 | GRTX | ↓ Sell | 1,002,212 | $8.25 | $8.3M | Direct | Jun 22, 2020 (3d) |
| Jun 17, 2020 | GRTX | ↓ Sell | 19,386 | $9.21 | $179K | Direct | Jun 17, 2020 (0d) |
| Jun 12, 2020 | GRTX | ↓ Sell | 17,232 | $9.33 | $161K | Direct | Jun 12, 2020 (0d) |
| Jun 9, 2020 | GRTX | ↓ Sell | 21,311 | $9.57 | $204K | Direct | Jun 9, 2020 (0d) |
| Jun 4, 2020 | GRTX | ↓ Sell | 14,965 | $9.68 | $145K | Direct | Jun 4, 2020 (0d) |
| Nov 12, 2019 | GRTX | ↑ Buy | 250,000 | $12.00 | $3.0M | Indirect | Nov 12, 2019 (0d) |
| May 28, 2019 | BCYC | ↑ Buy | 168,630 | $14.00 | $2.4M | Direct | May 30, 2019 (2d) |
| Apr 26, 2019 | ARPO | ↓ Sell | 701,800 | $1.03 | $723K | Indirect | Apr 29, 2019 (3d) |
| Apr 24, 2019 | ARPO | ↓ Sell | 51,057 | $1.02 | $52K | Indirect | Apr 24, 2019 (0d) |
| Apr 15, 2019 | ARPO | ↓ Sell | 117,140 | $1.05 | $123K | Indirect | Apr 15, 2019 (0d) |
| Apr 10, 2019 | ARPO | ↓ Sell | 200,746 | $1.07 | $214K | Indirect | Apr 10, 2019 (0d) |
| Apr 5, 2019 | ARPO | ↓ Sell | 130,594 | $0.99 | $129K | Indirect | Apr 5, 2019 (0d) |
| Apr 2, 2019 | ARPO | ↓ Sell | 231,763 | $0.94 | $219K | Indirect | Apr 2, 2019 (0d) |
| Apr 1, 2019 | ALRN | ↓ Sell | 127,150 | $1.86 | $236K | Direct | Apr 2, 2019 (1d) |
| Mar 28, 2019 | ARPO | ↓ Sell | 317,346 | $0.99 | $313K | Indirect | Mar 28, 2019 (0d) |
| Mar 15, 2019 | ALRN | ↓ Sell | 190,338 | $2.06 | $391K | Direct | Mar 15, 2019 (0d) |
| Aug 20, 2018 | ALRN | ↓ Sell | 20,388 | $2.30 | $47K | Direct | Aug 22, 2018 (2d) |
| Aug 20, 2018 | ARPO | ↓ Sell | 5,300 | $3.90 | $21K | Indirect | Aug 22, 2018 (2d) |
| Aug 17, 2018 | ALRN | ↓ Sell | 17,508 | $2.10 | $37K | Direct | Aug 20, 2018 (3d) |
| Aug 15, 2018 | ALRN | ↓ Sell | 5,935 | $2.21 | $13K | Direct | Aug 16, 2018 (1d) |
| Aug 13, 2018 | ALRN | ↓ Sell | 7,215 | $2.42 | $17K | Direct | Aug 14, 2018 (1d) |
| Aug 9, 2018 | ALRN | ↓ Sell | 1,235 | $2.72 | $3K | Direct | Aug 10, 2018 (1d) |
| Aug 7, 2018 | ALRN | ↓ Sell | 4,681 | $3.00 | $14K | Direct | Aug 8, 2018 (1d) |
| Aug 2, 2018 | ALRN | ↓ Sell | 4,702 | $3.33 | $16K | Direct | Aug 6, 2018 (4d) |
| Aug 1, 2018 | ALRN | ↓ Sell | 12,681 | $3.17 | $40K | Direct | Aug 2, 2018 (1d) |
| Jul 30, 2018 | ALRN | ↓ Sell | 8,458 | $3.35 | $28K | Direct | Jul 31, 2018 (1d) |
| Jul 26, 2018 | ALRN | ↓ Sell | 20,397 | $3.76 | $77K | Direct | Jul 27, 2018 (1d) |
| Jul 24, 2018 | ALRN | ↓ Sell | 31,300 | $4.25 | $133K | Direct | Jul 25, 2018 (1d) |
| Jul 17, 2018 | ALRN | ↓ Sell | 12,800 | $4.72 | $60K | Direct | Jul 18, 2018 (1d) |
| May 11, 2018 | AGLE | ↓ Sell | 19,550 | $10.06 | $197K | Direct | May 14, 2018 (3d) |
| May 10, 2018 | AGLE | ↓ Sell | 73,955 | $10.12 | $748K | Direct | May 11, 2018 (1d) |
| May 8, 2018 | AGLE | ↓ Sell | 42,105 | $10.06 | $424K | Direct | May 9, 2018 (1d) |
| Jul 5, 2017 | ALRN | ↑ Buy | 266,667 | $15.00 | $4.0M | Direct | Jul 5, 2017 (0d) |
| Jun 19, 2017 | RARX | ↓ Sell | 56,420 | $21.29 | $1.2M | Direct | Jun 20, 2017 (1d) |
| Jun 8, 2017 | RARX | ↓ Sell | 700 | $22.00 | $15K | Direct | Jun 12, 2017 (4d) |
| Jun 7, 2017 | RARX | ↓ Sell | 12,114 | $22.63 | $274K | Direct | Jun 8, 2017 (1d) |
| Jun 5, 2017 | RARX | ↓ Sell | 19,647 | $23.38 | $459K | Direct | Jun 6, 2017 (1d) |
| Jun 1, 2017 | RARX | ↓ Sell | 46,261 | $23.93 | $1.1M | Direct | Jun 2, 2017 (1d) |
| May 26, 2017 | RARX | ↓ Sell | 5,353 | $25.14 | $135K | Direct | May 30, 2017 (4d) |
| May 24, 2017 | RARX | ↓ Sell | 17,451 | $25.01 | $436K | Direct | May 25, 2017 (1d) |
| May 18, 2017 | RARX | ↓ Sell | 9,019 | $25.50 | $230K | Direct | May 22, 2017 (4d) |
| May 17, 2017 | RARX | ↓ Sell | 42,615 | $25.90 | $1.1M | Direct | May 18, 2017 (1d) |
| Mar 15, 2017 | NONE | ↑ Buy | 560,000 | $5.00 | $2.8M | Indirect | Mar 17, 2017 (2d) |
| Mar 1, 2017 | RARX | ↓ Sell | 84,615 | $20.96 | $1.8M | Direct | May 2, 2017 (62d) |
| Oct 31, 2016 | RARX | ↑ Buy | 84,615 | $13.00 | $1.1M | Direct | Oct 31, 2016 (0d) |
| Oct 31, 2016 | RARX | ↓ Sell | 339 | $13.00 | $4K | Direct | Oct 31, 2016 (0d) |
| Apr 12, 2016 | AGLE | ↑ Buy | 300,000 | $10.00 | $3.0M | Direct | Apr 12, 2016 (0d) |
| Feb 17, 2016 | PTI | ↑ Buy | 375,000 | $8.00 | $3.0M | Direct | Feb 17, 2016 (0d) |
| Jul 15, 2015 | TKAI | ↓ Sell | 3,566 | $14.26 | $51K | Direct | Jul 17, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Novartis Bioventures Ltd's insider trades
Novartis Bioventures Ltd is an insider at Akouos (AKUS). Since Jan 20, 2011, it has reported 11 open-market purchases worth $30.7M and 51 sales worth $22.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (12 filings), conversions (10 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AKUS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.